<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) is synthesized from <z:chebi fb="0" ids="13389">nicotinamide adenine dinucleotide</z:chebi> (<z:chebi fb="0" ids="15846">NAD(+)</z:chebi>) by poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP) and degraded by poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) glycohydrolase (PARG) </plain></SENT>
<SENT sid="1" pm="."><plain>Overactivation of the poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) pathway increases <z:chebi fb="0" ids="17154">nicotinamide</z:chebi> and decreases cellular <z:chebi fb="0" ids="15846">NAD(+)</z:chebi>/ATP, which leads to cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Blocking poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) metabolism by inactivating PARP has been shown to reduce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> injury </plain></SENT>
<SENT sid="3" pm="."><plain>We investigated whether disrupting the poly(<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) cycle by PARG inhibition could achieve similar protection </plain></SENT>
<SENT sid="4" pm="."><plain>We demonstrate that either pre- or post-<z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> treatment with 40 mg/kg of N-bis-(3-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-<z:chebi fb="1" ids="26308">propyl</z:chebi>)9-oxo-<z:chebi fb="0" ids="28266">fluorene</z:chebi>-2,7-<z:chebi fb="0" ids="48958">diamide</z:chebi>, a novel PARG inhibitor, significantly reduces brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes by 40-53% in a rat model of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Our result provides the first evidence that PARG inhibitors can ameliorate ischemic brain damage in vivo, in support of PARG as a new therapeutic target for treating <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> injury </plain></SENT>
</text></document>